Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9211 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9051 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD4380 |
Phase 2 |
0.8696 |
High Similarity |
NPD7054 |
Approved |
0.8642 |
High Similarity |
NPD7472 |
Approved |
0.8642 |
High Similarity |
NPD7074 |
Phase 3 |
0.8634 |
High Similarity |
NPD3818 |
Discontinued |
0.8599 |
High Similarity |
NPD7075 |
Discontinued |
0.8589 |
High Similarity |
NPD6797 |
Phase 2 |
0.8581 |
High Similarity |
NPD6801 |
Discontinued |
0.8537 |
High Similarity |
NPD7251 |
Discontinued |
0.8537 |
High Similarity |
NPD6559 |
Discontinued |
0.8526 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8408 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8373 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.828 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8239 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8158 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8121 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8079 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8065 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8063 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8063 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8025 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8013 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8012 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7898 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7871 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7848 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7844 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7814 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7791 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7742 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7688 |
Intermediate Similarity |
NPD8312 |
Approved |
0.764 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7588 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7578 |
Intermediate Similarity |
NPD920 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7453 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7389 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD37 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7341 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.734 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7337 |
Intermediate Similarity |
NPD919 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7251 |
Intermediate Similarity |
NPD1247 |
Approved |
0.725 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7215 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7189 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.717 |
Intermediate Similarity |
NPD6099 |
Approved |
0.717 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7169 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7134 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7086 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7065 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7051 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7032 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7017 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7240 |
Approved |
0.698 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6978 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD8319 |
Approved |
0.6963 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD943 |
Approved |
0.6948 |
Remote Similarity |
NPD2797 |
Approved |
0.6937 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6932 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD447 |
Suspended |
0.6914 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6908 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6904 |
Remote Similarity |
NPD7930 |
Approved |
0.6899 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6885 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6882 |
Remote Similarity |
NPD5889 |
Approved |
0.6882 |
Remote Similarity |
NPD5890 |
Approved |
0.6879 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6872 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6867 |
Remote Similarity |
NPD9545 |
Approved |
0.6864 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6848
|
Remote Similarity |
NPD2309 |
Approved |